Live

Latest

Newest first. Stories gain outlets as more of the press picks them up.

Trials & R&D · 4h ago

UChicago Medicine finaliza la fase de construcción del Pabellón Oncológico de la Fundación AbbVie, acercando a la realidad una nueva era en la atención del cáncer

1 outlet AbbVie

Deals & business · 5h ago

RNAi drug specialist ADARx raises $446M IPO

1 outlet

Approvals & regulatory · 5h ago

XtalPi Submits U.S. FDA IND Application for KQTD-126, a Potential First-in-Class, Gut-Restricted Pan-TRK Inhibitor for Chronic Intestinal Pain

1 outlet FDA

Deals & business · 7h ago

Alphabet and Meta now spend nearly as much on R&D as pharma’s 10 largest drugmakers

1 outlet Johnson & Johnson Roche

Trials & R&D · 8h ago

Global Autoimmune Treatment Market to Reach USD 321.95 Billion by 2034, Driven by Rising Prevalence of Autoimmune Diseases, Growing Adoption of Biologics, and Advances in Precision Medicine Says Maximize Market Research

1 outlet

Approvals & regulatory · 8h ago

FDA Nominee Voices Support for Vaccines at Senate Hearing Scrutinizing Trump's Moves

1 outlet Vaccines & mRNA FDA

Approvals & regulatory · 9h ago

Grail multicancer detection test wins FDA advisers’ backing

1 outlet FDA

Trials & R&D · 9h ago

Muscle Cell Calcium Channel Structure, Synchronicity Could Advance Muscle Disease Therapeutics

1 outlet

Approvals & regulatory · 9h ago

FDA Approves New Option for Previously Treated Bile Duct Cancer

1 outlet FDA

Approvals & regulatory · 9h ago

STAT+: Heidi Overton, Trump’s pick for FDA head, to face questions at Senate hearing

2 outlets FDA

Approvals & regulatory · 9h ago

Where does FDA nominee Overton stand on vaccines and other key pharma issues?

1 outlet Vaccines & mRNA FDA

Approvals & regulatory · 9h ago

Merck Welireg, Eisai Lenvima combo approved for kidney cancer

1 outlet Merck & Co. (MSD)

Deals & business · 9h ago

New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™

1 outlet

Approvals & regulatory · 10h ago

STAT+: FDA commissioner nominee Heidi Overton keeps opinions to herself in Senate hearing

1 outlet Vaccines & mRNA FDA

Trials & R&D · 10h ago

Renibus Therapeutics Announces Participation at the Oppenheimer Private Life Sciences Company Showcase

1 outlet

Trials & R&D · 10h ago

JNC Targets Bigger Molecules with Cellufine

1 outlet Vaccines & mRNA

Trials & R&D · 10h ago

Pfizer: Poised For Gains With A New Drug Pipeline And Cost-Cutting Plans

1 outlet Pfizer

Approvals & regulatory · 10h ago

FDA commissioner nominee Overton rebuffs questions about Trump medical claims

1 outlet FDA

Approvals & regulatory · 10h ago

The FDA’s Overton era, and dispatches from Shanghai

1 outlet FDA

Trials & R&D · 11h ago

AC Immune: Buy Continued ACI-7104 Progress, PD, And Pipeline Expansions

1 outlet

Pricing & policy · 11h ago

NSF Funds ISS National Lab-Sponsored Projects to Advance Applications in Electronics Cooling and Drug Delivery

1 outlet

Manufacturing & supply · 11h ago

UChicago Medicine completes construction phase of AbbVie Foundation Cancer Pavilion, bringing new era of cancer care closer to reality

1 outlet AbbVie

Trials & R&D · 11h ago

Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly

1 outlet Eli Lilly

Approvals & regulatory · 11h ago

FDA adcomm votes in favor of benefit-risk of Grail’s cancer test

4 outlets FDA

Trials & R&D · 11h ago

Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing

1 outlet Gene therapy & editing

Trials & R&D · 11h ago

Possible Drug-Drug Interactions Flagged for Older Americans

1 outlet

Approvals & regulatory · 11h ago

FDA slams GLP-1 compounder over risk of contaminating drugs ‘with filth’

1 outlet GLP-1 & obesity drugs Eli Lilly FDA

Approvals & regulatory · 11h ago

Altruist Biologics preps for production following EMA GMP certification

2 outlets EMA

Deals & business · 11h ago

Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to Start R&D Pact

1 outlet Eli Lilly

Pricing & policy · 11h ago

Nurse Spreads Vaccine Misinfo; MD vs PBM; Growing Pains or Red Flags?

1 outlet Vaccines & mRNA Drug pricing

Trials & R&D · 12h ago

Riaan’s Therapeutic Odyssey – Chapter 4: The Drug Developers

1 outlet

Approvals & regulatory · 12h ago

Senators grill FDA nominee Heidi Overton

2 outlets FDA

Approvals & regulatory · 12h ago

U.S. Food and Drug Administration (FDA) approves Lilly's Onswik™ (insulin efsitora alfa-gobe), a once-weekly basal insulin injection treatment for adults living with type 2 diabetes

4 outlets Eli Lilly FDA

Deals & business · 13h ago

Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies

1 outlet CAR-T & cell therapy

Trials & R&D · 13h ago

Experimental Drug Could Reverse Multiple Sclerosis Damage

1 outlet

Approvals & regulatory · 13h ago

FGFR2 inhibitor Lyrfigtu wins FDA approval for bile duct cancer

3 outlets FDA

Trials & R&D · 13h ago

Cullinan drops after delaying early-stage trial data for arthritis therapy

1 outlet

Approvals & regulatory · 14h ago

Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalry

2 outlets Eli Lilly FDA

Deals & business · 14h ago

Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 crore

1 outlet Sanofi

Trials & R&D · 14h ago

The 30-Minute Medicine Problem

1 outlet

Approvals & regulatory · 14h ago

GRAIL's Galleri test wins endorsement from FDA panel

2 outlets FDA

Deals & business · 14h ago

Lilly extends China innovation push in $3.35B Innocare deal

1 outlet Eli Lilly

Trials & R&D · 14h ago

N-of-1 therapies to address rare diseases with no commercial interest

1 outlet

Approvals & regulatory · 14h ago

Regulatory: FDA nods for Intrabio, Nuvation, Fempulse, Xenix and more

1 outlet Eli Lilly AstraZeneca

Deals & business · 14h ago

Earendil’s AI platform lands $1.5B Genentech collaboration

1 outlet Roche

Deals & business · 14h ago

An instinct about Atavistik? Roche signs $1.9B-plus deal

1 outlet Roche

Approvals & regulatory · 14h ago

Awiqli insulin, this time for Lilly, with FDA-cleared Onswik

1 outlet Eli Lilly FDA

Manufacturing & supply · 14h ago

Enveda raises a $311M series E for pipeline of plant-discovered molecules

1 outlet

Trials & R&D · 14h ago

DME red flag in Merck Brunello phase III? Surrozen finishes rich

1 outlet Merck & Co. (MSD)

Approvals & regulatory · 14h ago

GRAIL sets new 52-week high as FDA panel backs cancer test

1 outlet FDA

Manufacturing & supply · 14h ago

ACROBiosystems Introduces CHO-Direct and ACRO AIx to Accelerate AI-driven Drug Discovery

1 outlet

Approvals & regulatory · 14h ago

Marani Health Receives FDA Clearance for M•care System, Clearing the Path Toward Commercial Launch

1 outlet FDA

Trials & R&D · 14h ago

Acadia Pharmaceuticals: Remlifanserin Is In Trouble

1 outlet

Trials & R&D · 14h ago

Video on function-focused antibody discovery workflows with Envisia

1 outlet

Deals & business · 14h ago

Merck reveals study success, and possible safety worries, for eye drug hopeful

1 outlet Merck & Co. (MSD)

Trials & R&D · 14h ago

MSD’s DME drug could challenge anti-VEGF reign, late-stage study suggests

1 outlet Merck & Co. (MSD)

Approvals & regulatory · 14h ago

FDA Panel Narrowly Backs Multi-Cancer Blood Test Despite Doubts It Works

1 outlet FDA

Trials & R&D · 14h ago

Roche secures separate discovery deals with Atavistik, Earendil

1 outlet Roche

Trials & R&D · 14h ago

10-Year Data Back Early Start to Biologics in Arthritic Diseases

1 outlet

Trials & R&D · 15h ago

J&J says analysis demonstrates potential of Tecvayli-Darzalex combo for multiple myeloma

2 outlets Johnson & Johnson

Trials & R&D · 15h ago

Sarepta to pay Regenxbio $39M to settle gene therapy claims; Vida eyes fourth fund

1 outlet Gene therapy & editing

Trials & R&D · 15h ago

Acadia falls after mid-stage trial setback for Alzheimer’s psychosis therapy

2 outlets Alzheimer's drugs

Trials & R&D · 15h ago

Johnson County ClinTrials (JCCT) Rebrands as Sequoia Clinical Research

1 outlet Vaccines & mRNA

Approvals & regulatory · 15h ago

AstraZeneca granted EU label expansion for COPD therapy, Trixeo in asthma

2 outlets AstraZeneca

Trials & R&D · 15h ago

Six reasons to register for Drug Discovery Innovators & Investors UK Conference

1 outlet

Trials & R&D · 15h ago

Chronic Kidney Disease Market: 5 Emerging Therapies to Watch as the Treatment Landscape Expected to Evolve by 2036 | DelveInsight

1 outlet CAR-T & cell therapy

Deals & business · 16h ago

Arcturus raised to Buy at Citi after mid-stage trial data for liver disease drug

1 outlet

Trials & R&D · 16h ago

Acadia slides on Phase 2 miss in Alzheimer’s psychosis but keeps moving asset forward

1 outlet Alzheimer's drugs

Deals & business · 16h ago

Daiichi Sankyo expands Turbine collaboration to accelerate ADC discovery

1 outlet Antibody-drug conjugates Daiichi Sankyo

Deals & business · 16h ago

Lilly’s latest China drug deal; Immunovant’s setback in lupus

1 outlet Eli Lilly Vertex

Approvals & regulatory · 16h ago

Trump's FDA pick Heidi Overton calls vaccines, mifepristone safe and effective in confirmation hearing

1 outlet Vaccines & mRNA FDA

Trials & R&D · 16h ago

ELEPHAS BIOSCIENCES AND TES PHARMA COLLABORATE TO ADVANCE TRANSLATIONAL RESEARCH FOR LUNG CANCER THERAPY

1 outlet

Approvals & regulatory · 16h ago

Eli Lilly outlays $3.35bn for secretive drug discovery pact with China’s InnoCare

1 outlet Eli Lilly

Approvals & regulatory · 16h ago

Merck’s experimental eye drug matches Roche’s VEGF inhibitor but safety concerns emerge

1 outlet Merck & Co. (MSD) Roche

Trials & R&D · 16h ago

Novo Nordisk: Capital Markets Day Reveals Its Next Growth Engine

1 outlet Novo Nordisk

Trials & R&D · 16h ago

United Therapeutics, Sagimet drop after Goldman Sachs Sell ratings

1 outlet

Trials & R&D · 16h ago

Roche, Atavistik Bio partner on allosteric drug discovery

1 outlet Roche

Approvals & regulatory · 17h ago

Kyverna steps closer to FDA-first CAR T for an autoimmune condition with durability data

1 outlet CAR-T & cell therapy FDA

Approvals & regulatory · 17h ago

STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more

1 outlet Eli Lilly FDA

Trials & R&D · 17h ago

CancerIQ Deepens EHR Integrations to Identify and Guide More Patients Through Cancer Screening, Testing and Surveillance

1 outlet